Major pharmaceutical firms Moderna and Merck promote new mRNA cancer vaccine to stop melanoma from coming back.
Two pharmaceutical companies based in the U.S. have reported encouraging results from a “Phase 3 clinical trial” indicating that a personalized mRNA cancer vaccine can enhance patient outcomes when combined with standard immunotherapy for those with high-risk melanoma. This experimental treatment, known as intismeran autogene (mRNA-4157/V940), was jointly developed by Moderna and Merck. It achieved […]
Moderna Shares Surge More Than 100%
Moderna and Merck’s Cancer Vaccine Trials Show Promise On Wednesday, shares of Moderna experienced a significant surge, more than doubling in value, following the announcement of positive outcomes from late-stage trials of their cancer vaccines in collaboration with Merck. However, detailed data on these results has not yet been made public. According to the companies, […]
Moderna caught off guard by FDA’s decision to not review flu vaccine application
FDA Rejects Moderna’s mRNA Influenza Vaccine Application The Food and Drug Administration has declined to review Moderna’s application for a new mRNA influenza vaccine. Dr. Stephen Hoge, the president of Moderna, expressed that he found this decision to be “completely shocking.” In an exclusive conversation, Hoge admitted to being “completely surprised and frankly quite confused” […]
S&P 500 Movements Today: Moderna Drops; Synopsys Rises Due to Nvidia Agreement
Important points On Monday, December 1, 2025, while there are worries about tighter regulations for vaccine manufacturers, one chip design software company found some good news thanks to a partnership with a leading AI firm. Moderna’s stock dropped after news that U.S. health authorities are looking to make the vaccine approval process more stringent. Shares […]
Shares of Pfizer and Moderna fall after report that Trump officials intend to connect child fatalities to COVID vaccine
On Friday, shares of Pfizer and Moderna dropped by 3.9% and 7.4%, respectively, following news that officials plan to associate the deaths of 25 children with a joint COVID vaccine. Health officials from the Trump administration intend to present this information during next week’s meeting of the CDC’s advisory panel, which will evaluate recommendations for […]
Moderna will reduce its workforce by 10% as part of significant cost-saving efforts.
Moderna Announces Workforce Reduction Moderna has revealed plans to trim its global workforce by about 10%, which would leave it with less than 5,000 employees by year-end. This move, announced on Thursday, aligns with the company’s goal to cut annual operating expenses by around $1.5 billion by 2027, according to CEO Stéphane Bancel. The company […]
FDA grants limited approval for new Moderna COVID vaccine
Moderna’s New COVID-19 Vaccine Approved by FDA The FDA has given the green light to Moderna’s latest COVID-19 vaccine, known as Mnexspike. This new option is specifically aimed at adults aged 65 and older, along with younger individuals, ages 12 to 64, who have at least one underlying medical condition that puts them at higher […]
HHS weighs rescinding Moderna bird flu vaccine contract
The Trump administration has confirmed it is reevaluating the $590 million human avian flu vaccine contract awarded to Moderna on the waning day of the Biden administration. “It is important for the U.S. sector and health and welfare welfare to help prepare for the pandemic, but for four years of Biden administration surveillance, a spokesperson […]
Moderna CEO Said He Knew in 2019 a Lucrative Pandemic Would Happen
Estimated Reading Time: < 1 minute During the January 18 World Economic Forum (WEF) panel State of the Pandemic at Davos 2023, Moderna CEO said, “When the [COVID] pandemic happened, Moderna had made a hundred thousand doses in 2019 for the whole year. And I remember walking after those into the office of my other […]